XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2

Stockholders’ Equity (Tables)

9 Months Ended

Sep. 30, 2021

Stockholders' Equity Note [Abstract]

Schedule of warrant and stock option grants with time-based vesting

		Warrant Grants								Stock Option Grants								Restricted Stock Units
		Number of shares subject to warrants				Weighted- average exercise price per share				Number of shares subject to options				Weighted- average exercise price per share				Number of shares subject to restricted stock units
Balance at December 31, 2020			672,459			$	8.09				118,388			$	3.25				2,301,053
Granted			389,344				2.30				-				-				843,338
Exercised			-				-				-				-				(675,219	)
Expired			(11,699	)			-				-				-				(150,833	)
Balance at September 30, 2021			1,050,104			$	2.57				118,388			$	3.25				2,318,339
Exercisable at September 30, 2021			1,050,104			$	2.57				118,388			$	3.25				1,464,631

Schedule of fair value of the warrants as of original issuance date

		Issuance date
Risk-free interest rate			0.49 - 0.88	%
Expected dividend yield			-	%
Expected volatility			100	%
Term			5 years
Fair value of common stock			1.95 - 2.24

Schedule of company’s outstanding warrants and options

Warrants Outstanding																Warrants Exercisable
Exercise Price Range				Number Outstanding				Weighted Average Remaining Contractual Life (in years)				Weighted Average Exercise Price				Number Exercisable			Weighted Average Exercise Price				Intrinsic Value
$	1.79 - $20.90				1,050,104				3.23			$	2.57			1,050,104			$	2.57				290,525

Options Outstanding																Options Exercisable
Exercise Price Range				Number Outstanding				Weighted Average Remaining Contractual Life (in years)				Weighted Average Exercise Price				Number Exercisable			Weighted Average Exercise Price				Intrinsic Value
$	2.64 - $28.50				118,388				2.94			$	3.25			118,388			$	3.25				-

Schedule of stock-based compensation expense

		For the three months ended								For the nine months ended
		September 30,								September 30,
		2021				2020				2021				2020
Stock-based compensation expense		$	699,084			$	488,304			$	1,929,446			$	2,844,851

Schedule of stock-based compensation expense categorized by the equity components

		For the three months ended								For the nine months ended
		September 30,								September 30,
		2021				2020				2021				2020
Common stock		$	699,084			$	488,304			$	1,929,446			$	2,844,851
Total		$	699,084			$	488,304			$	1,929,446			$	2,844,851

X

- Definition

Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of stock-based compensation expense.

+ References

No definition available.

+ Details

Name:	worx_ScheduleOfStockbasedCompensationExpenseTableTextBlock
Namespace Prefix:	worx_
Data Type:	dtr:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of stock-based compensation expense categorized by equity components.

+ References

No definition available.

+ Details

Name:	worx_StockbasedCompensationExpenseCategorizedByEquityComponentsTableTextBlock
Namespace Prefix:	worx_
Data Type:	dtr:textBlockItemType
Balance Type:	na
Period Type:	duration